<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(2)</volume><submitter>Shipp C</submitter><pubmed_abstract>Heat shock proteins (hsps) have been studied in numerous cancer types, but a clear view of their clinical relevance in melanoma remains elusive. Therefore, the aim of this study was to investigate the expression of hsps in melanoma with respect to patient clinical parameters. Using Western immunoblotting, hsps 90, 70, 60, 40 and 32 were observed to be widely expressed in metastatic melanomas (n = 31), while immunofluorescence demonstrated that in the majority of samples these hsps, apart from hsp32, were increased in expression in melanoma cells compared with surrounding non-melanoma cells in situ (n = 8). Correlating hsp expression with patient clinical parameters indicated that greater hsp90 (P &lt; 0.02) and hsp40 (P &lt; 0.03) expression correlated with advanced stage (stage III Vs stage IV)</pubmed_abstract><journal>Cell stress &amp; chaperones</journal><pagination>145-54</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3581625</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Hsps are up-regulated in melanoma tissue and correlate with patient clinical parameters.</pubmed_title><pmcid>PMC3581625</pmcid><pubmed_authors>Weide B</pubmed_authors><pubmed_authors>Derhovanessian E</pubmed_authors><pubmed_authors>Pawelec G</pubmed_authors><pubmed_authors>Shipp C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hsps are up-regulated in melanoma tissue and correlate with patient clinical parameters.</name><description>Heat shock proteins (hsps) have been studied in numerous cancer types, but a clear view of their clinical relevance in melanoma remains elusive. Therefore, the aim of this study was to investigate the expression of hsps in melanoma with respect to patient clinical parameters. Using Western immunoblotting, hsps 90, 70, 60, 40 and 32 were observed to be widely expressed in metastatic melanomas (n = 31), while immunofluorescence demonstrated that in the majority of samples these hsps, apart from hsp32, were increased in expression in melanoma cells compared with surrounding non-melanoma cells in situ (n = 8). Correlating hsp expression with patient clinical parameters indicated that greater hsp90 (P &lt; 0.02) and hsp40 (P &lt; 0.03) expression correlated with advanced stage (stage III Vs stage IV)</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Mar</publication><modification>2025-04-25T21:53:04.366Z</modification><creation>2019-03-27T01:05:13Z</creation></dates><accession>S-EPMC3581625</accession><cross_references><pubmed>22872370</pubmed><doi>10.1007/s12192-012-0363-1</doi></cross_references></HashMap>